+1,100.9%
MRNA vs STT
+239.1%
+861.8%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | STT | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.1% | -3.3% | -3.4% |
| 7D | -12.1% | +4.8% | -16.9% | -12.7% |
| 30D | -1.3% | +3.9% | -5.2% | -1.7% |
| 3M | +250.9% | -8.2% | +259.1% | +254.0% |
| 6M | +343.0% | +15.6% | +327.4% | +328.3% |
| YTD | +657.4% | +37.6% | +619.8% | +608.7% |
| 1Y | +794.9% | +50.1% | +744.8% | +725.7% |
| 3Y | +218.1% | +183.1% | +35.1% | +170.6% |
| 5Y | -3.4% | +104.8% | -108.2% | -19.8% |
| All | +1,100.9% | +239.1% | +861.8% | +905.6% |
Cumulative growth
Daily Returns
Daily percentage return beside STT.
Daily Out/Under-Performance
Portfolio return minus STT return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × STT return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded STT wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling